JPRN-UMIN000014079已完成未知
Pilot study of FOLFOX/FOLFIRI for locally advanced and metastatic pancreatic cancer - FOLFOX/FOLFIRI for locally advanced and metastatic pancreatic cancer
Osaka Medical College Hospital0 个研究点目标入组 100 人开始时间: 2014年5月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) with pulmonary fibrosis or interstitial pneumonia which can be detected from X-ray incontrovertibly or has clinical symptom 2) with severe diarrhea within 3 days before entry 3) with other severe diseases (heart failure, renal disfunction, liver disfunction, intestinal paralysis, ileus, uncontrolled DM) 4) patients whom administered Flucitosine or Fenitoin or Warfarin 5) with active double cancers whose disease free period is shorter than 5 years, Carcinoma in situ can be excluded. 6) with infectious disease which needs therapy 7) with body temperature over 38 degrees Celsius 8) women who are pregnant or expect to be pregnant, or nursing female 9) patients whom doctor in chief decides not to register to this study due to psychological disease or symptoms 10) general administration of steroids 11) with indication of FOLFIRINOX therapy 12) in the case of receiving adjuvant chemotherapy, recurrence within 180 days from the last administration of adjuvant chemotherapy
研究者
相似试验
进行中（未招募）
不适用
Phase II trial to evaluate the combination of FOLFOX6 + Bevacizumab in initially unresectable liver metastases from colorectal cancerMETASTHATIC COLON-RECTUM AND KIDNEY CANCERMedDRA version: 9.1Level: LLTClassification code 10055114Term: Colon cancer metastaticEUCTR2005-002269-35-ITAZIENDA OSPEDALIERA POLICLINICO DI MODENA
进行中（未招募）
不适用
Essai de phase II évaluant l'association de FOLFOX et CETUXIMAB avec radiothérapie concomitante en traitement des cancers de l'oesophage de stade III - ERAFOXCarcinome epidermoïde ou glandulaire de l'oesophage de satde III histologiquement prouvé. Tumeurs du cardia à développement oesophagien acceptéesMedDRA version: 8.1Level: PTClassification code 10030151Term: cancer oesophageEUCTR2006-005550-72-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
已完成
2 期
A pilot study of Focal Ablative Stereotactic Radiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases.Primary Renal Cell CarcinomaMetastatic non-small cell carcinoma to the adrenal glandCancer - KidneyCancer - Other cancer typesACTRN12612000759897Dr Shankar Siva30
招募中
不适用
Translational Research of Phase II study of FOLFIRI+Ramucirumab with early recurrent colorectal cancer refractory to adjuvant chemotherapy with oxaliplatin / fluoropyrimidine (RAINCLOUD)Colorectal CancerJPRN-UMIN000028678MCSGO: Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group40
进行中（未招募）
不适用
Randomized, Phase 2 Study of FOLFOX or FOLFIRI with AG-013736 or Bevacizumab in Patients with Metastatic Colorectal Cancer after Failure of an Irinotecan or Oxaliplatin-containing First-line RegimeSecond line treatment of patients with metastatic carcinoma of colon and rectumMedDRA version: 9.1Level: LLTClassification code 10052362Term: Metastatic colorectal cancerMedDRA version: 9.1Level: PTClassification code 10052358Term: Colorectal cancer metastaticEUCTR2007-006283-30-CZPfizer Inc, 235 East 42nd Street, New York, NY 10017, USA176